Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-26 Sale | 2024-11-27 5:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,469 | $250.98 | $368,686 | 13,191 (Direct) | View |
| 2024-06-25 Sale | 2024-06-26 4:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,605 | $231 | $370,747 | 11,660 (Direct) | View |
| 2024-02-28 Sale | 2024-02-29 4:18 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 501 | $155.3 | $77,805 | 8,569 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 4:08 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,009 | $148.06 | $149,397 | 4,070 (Direct) | View |
| 2023-04-27 Sale | 2023-04-28 5:55 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,476 | $194.59 | $287,215 | 1,801 (Direct) | View |
| 2023-02-02 Sale | 2023-02-03 5:45 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 5,025 | $230.19 | $1,156,692 | 0 (Direct) | View |
| 2022-08-03 Sale | 2022-08-05 4:15 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,595 | $214.18 | $769,970 | 0 (Direct) | View |
| 2022-07-05 Sale | 2022-07-07 4:06 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,754 | $150 | $263,100 | 1,754 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-25 Option Award | 2024-11-27 5:21 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,000 | $0 | 13,191 (Direct) | View |
| 2024-11-11 Option Award | 2024-11-13 5:34 pm | N/A 2034-11-10 | Lexeo Therapeutics Inc. | LXEO | Tanguler Tolga Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,278 | $0 | 11,660 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:22 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 14,030 | $0 | 19,266 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:18 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,667 | $0 | 8,569 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:08 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,278 | $0 | 4,070 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 5:55 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,277 | $0 | 1,801 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:21 pm | N/A 2026-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 15,352 | $0 | 15,352 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 5:45 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 5,025 | $0 | 0 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:15 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,618 | $189.76 | 0 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:15 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 170 | $210.5 | 0 (Direct) | View |
| 2022-08-03 Option Award | 2022-08-05 4:15 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,629 | $0 | 0 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:12 pm | N/A 2032-02-22 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 18,413 | $0 | 18,413 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-03 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 5,026 | $0 | 8,533 (Direct) | View |
| 2022-02-02 Tax Withholding | 2022-02-03 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,518 | $144.67 | 8,533 (Direct) | View |
Ownership | 2021-03-10 4:06 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 0 | $0 | 66,514 (Direct) | View |